Survival of de novo stage IV breast cancer patients over three decades

Surgery of the primary tumor in de novo metastatic breast cancer: To do or not to do?

(2015) C. Criscitiello et al.   EJSO

Survival of older patients with metastasised breast cancer lags behind despite evolving treatment strategies – A population-based study

(2015) N.A. de Glas et al.   EUROPEAN JOURNAL OF CANCER

Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial

(2015) Rajendra Badwe et al.   LANCET ONCOLOGY

Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer

(2015) Sandra M. Swain et al.   NEW ENGLAND JOURNAL OF MEDICINE

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†

(2014) F. Cardoso et al.   ANNALS OF ONCOLOGY

Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer

(2014) Denise A. Yardley et al.   BREAST CANCER RESEARCH AND TREATMENT

Abstract S2-03: Early follow up of a randomized trial evaluating resection of the primary breast tumor in women presenting with de novo stage IV breast cancer; Turkish study (protocol MF07-01)

(2014) A Soran et al.   CANCER RESEARCH

Metastatic breast cancer: are we treating the same patients as in the past?

(2013) M.-P. Ufen et al.   ANNALS OF ONCOLOGY

Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study

(2013) S Walters et al.   BRITISH JOURNAL OF CANCER

A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up

(2012) S. J. Johnston et al.   ANNALS OF ONCOLOGY

Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

(2012) Douglas Hanahan et al.   CANCER CELL

Why RECIST Works and Why It Should Stay--Counterpoint

(2012) A. T. Fojo et al.   CANCER RESEARCH

Overall Survival: Patient Outcome, Therapeutic Objective, Clinical Trial End Point, or Public Health Measure?

(2012) Everardo D. Saad et al.   JOURNAL OF CLINICAL ONCOLOGY

Unfavourable pattern of metastases in M0 breast cancer patients during 1978-2008: a population-based analysis of the Munich Cancer Registry

(2011) Corina J. G. van den Hurk et al.   BREAST CANCER RESEARCH AND TREATMENT

Improved survival of patients with primary distant metastatic breast cancer in the period of 1995–2008. A nationwide population-based study in the Netherlands

(2011) J. Ruiterkamp et al.   BREAST CANCER RESEARCH AND TREATMENT

Associations between first and second primary cancers: a population-based study

(2011) S. F. Nielsen et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Survival differences among women with de novo stage IV and relapsed breast cancer

(2010) S. Dawood et al.   ANNALS OF ONCOLOGY

Integrating molecular profiling, histological type and other variables: Defining the fingerprint of responsiveness to treatment

(2009) Giuseppe Viale   BREAST

Impact of breast surgery on survival in patients with distant metastases at initial presentation: a systematic review of the literature

(2009) Jetske Ruiterkamp et al.   BREAST CANCER RESEARCH AND TREATMENT

Chemotherapy in metastatic breast cancer: A summary of all randomised trials reported 2000–2007

(2008) Nicholas Wilcken et al.   EUROPEAN JOURNAL OF CANCER

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Trends in Survival Over the Past Two Decades Among White and Black Patients With Newly Diagnosed Stage IV Breast Cancer

(2008) Shaheenah Dawood et al.   JOURNAL OF CLINICAL ONCOLOGY